Foundry Partners’s Core Laboratories CLB Stock Holding History

Foundry Partners’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-48,345	Closed	-$9.59M	–	261
2014 Q1	$9.59M	Buy	48,345 +13,333	+38%	+$2.52M	0.9%	26
2013 Q4	$6.69M	Buy	+35,012	New	+$6.52M	0.6%	65

Other funds holding CLB

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Foundry Partners's CLB Position: Q2 2014 in Review

Foundry Partners sold out of Core Laboratories (CLB) in Q2 2014, closing a stake of 48,345 shares — an estimated $9.59M sold.

Foundry Partners first reported a position in CLB in Q4 2013 and held it in 2 quarters. The position peaked at $9.59M in Q1 2014. 346 funds tracked by Wall St. Rank hold CLB as of Q2 2014.

Foundry Partners reported no remaining Core Laboratories position as of Q2 2014 after selling out during the quarter.
Foundry Partners sold 48,345 Core Laboratories shares in Q2 2014, an estimated $9.59M.
Foundry Partners first reported a position in Core Laboratories in Q4 2013 and held it in 2 quarters.
Foundry Partners's Core Laboratories position peaked at $9.59M in Q1 2014.
346 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2014.

Based on Foundry Partners's 13F filing for Q2 2014, filed 7 Jul 2014.